Alpha 2.0
Login Register
» Authors » H Foth

H Foth

Explore the profile of H Foth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 282
Followers 0
Related Specialties
Toxicology
Pharmacology
Biochemistry
Top 10 Co-Authors
G F Kahl
R Kahl
K I Hirsch-Ernst
T Gebel
U Gundert-Remy
E Schrader
J G Hengstler
H C Michaelis
W P Geng
G Damm
Published In
Arch Toxicol
Toxicology
Naunyn Schmiedebergs Arch Pharmacol
Biochem Biophys Res Commun
Drug Metab Dispos
Affiliations
Soon will be listed here.
Recent Articles
1.
Modular air-liquid interface aerosol exposure system (MALIES) to study toxicity of nanoparticle aerosols in 3D-cultured A549 cells in vitro
Kustner M, Eckstein D, Brauer D, Mai P, Hampl J, Weise F, et al.
Arch Toxicol . 2024 Feb; 98(4):1061-1080. PMID: 38340173
We present a novel lung aerosol exposure system named MALIES (modular air-liquid interface exposure system), which allows three-dimensional cultivation of lung epithelial cells in alveolar-like scaffolds (MatriGrids) and exposure to...
2.
New aspects in deriving health-based guidance values for bromate in swimming pool water
Rohl C, Batke M, Damm G, Freyberger A, Gebel T, Gundert-Remy U, et al.
Arch Toxicol . 2022 Apr; 96(6):1623-1659. PMID: 35386057
Bromate, classified as a EU CLP 1B carcinogen, is a typical by-product of the disinfection of drinking and swimming pool water. The aim of this study was (a) to provide...
3.
The EU chemicals strategy for sustainability: critical reflections on proposed regulatory changes for endocrine disruptors and mixture toxicity
Batke M, Damm G, Foth H, Freyberger A, Gebel T, Gundert-Remy U, et al.
Arch Toxicol . 2022 Feb; 96(4):1133-1135. PMID: 35122513
No abstract available.
4.
Critical evaluation of human health risks due to hydraulic fracturing in natural gas and petroleum production
Wollin K, Damm G, Foth H, Freyberger A, Gebel T, Mangerich A, et al.
Arch Toxicol . 2020 May; 94(4):967-1016. PMID: 32385535
The use of hydraulic fracturing (HF) to extract oil and natural gas has increased, along with intensive discussions on the associated risks to human health. Three technical processes should be...
5.
Safety of nanomaterials
Foth H, Stewart J, Gebel T, Bolt H
Arch Toxicol . 2012 Jun; 86(7):983-4. PMID: 22733142
No abstract available.
6.
Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A
Hengstler J, Foth H, Gebel T, Kramer P, Lilienblum W, Schweinfurth H, et al.
Crit Rev Toxicol . 2011 Mar; 41(4):263-91. PMID: 21438738
Despite the fact that more than 5000 safety-related studies have been published on bisphenol A (BPA), there seems to be no resolution of the apparently deadlocked controversy as to whether...
7.
Background of REACH in EU regulations on evaluation of chemicals
Foth H, Hayes A
Hum Exp Toxicol . 2008 Sep; 27(6):443-61. PMID: 18784197
Industrial chemicals are needed for chemical synthesis or technical purposes. These beneficial effects are counterbalanced by the potential health risks for all who come into contact with them. The new...
8.
Concept of REACH and impact on evaluation of chemicals
Foth H, Hayes A
Hum Exp Toxicol . 2008 May; 27(1):5-21. PMID: 18480145
Industrial chemicals have been in use for many decades and new products are regularly invented and introduced to the market. Also for decades, many different chemical laws have been introduced...
9.
Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH)
Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler J, Kahl R, et al.
Arch Toxicol . 2008 Mar; 82(4):211-36. PMID: 18322675
During the last two decades, substantial efforts have been made towards the development and international acceptance of alternative methods to safety studies using laboratory animals. In the EU, challenging timelines...
10.
The REACH concept and its impact on toxicological sciences
Hengstler J, Foth H, Kahl R, Kramer P, Lilienblum W, Schulz T, et al.
Toxicology . 2006 Mar; 220(2-3):232-9. PMID: 16555380
No abstract available.